Refoxy Pharma
PrivateLast Round
Seed
Dec 4, 2024
Total Funding Raised
$15.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Refoxy Pharma is a biotechnology company developing small molecule activators of the FOXO3 transcription factor for the treatment of age-related diseases, with an initial focus on idiopathic pulmonary fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Refoxy Pharma Comparables
Compare Refoxy Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Isterian Biotech | 81% | |
| Oorja Bio, Inc. | 78% | |
| Mediar Therapeutics | 71% | |
Refoxy Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 4, 2024 | ||||
| Seed | Nov 30, 2022 | ||||
| Seed | Aug 1, 2021 |
Refoxy Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NRW.Venture | Seed |
| Boehringer Ingelheim | Seed |
| NRW.Bank | Seed |
| Korify Capital | Seed |
| Boehringer Ingelheim Venture Fund | Seed |
| High-Tech Gründerfonds | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors grew 300% MoM, reaching 977.
- Dec 4, 2024
$9.7M round led by Boehringer Ingelheim.
Refoxy Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Refoxy Pharma's valuation, stock price, and market status.